Melanoma: Staging and Follow-Up

Cancer staging is the process determining to which extent a cancer has spread and where it is located in the body. A thorough staging is of utmost importance, not only because it provides the most accurate prognostic estimation, but also because several crucial decisions, such as the treatment choi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chryssoula Papageorgiou, Zoe Apalla, Sofia-Magdalini Manoli, Konstantinos Lallas, Efstratios Vakirlis, Aimilios Lallas
Formato:	article
Lenguaje:	EN
Publicado:	Mattioli1885 2021
Materias:	Melanoma staging follow-up Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/16a49f013e7d4ebeae8ac1918b14e2c7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:16a49f013e7d4ebeae8ac1918b14e2c7
record_format	dspace
spelling	oai:doaj.org-article:16a49f013e7d4ebeae8ac1918b14e2c72021-11-17T08:27:40ZMelanoma: Staging and Follow-Up10.5826/dpc.11S1a162S2160-9381https://doaj.org/article/16a49f013e7d4ebeae8ac1918b14e2c72021-07-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/1795https://doaj.org/toc/2160-9381 Cancer staging is the process determining to which extent a cancer has spread and where it is located in the body. A thorough staging is of utmost importance, not only because it provides the most accurate prognostic estimation, but also because several crucial decisions, such as the treatment choice and the follow-up strategy, vary according to the tumor’s stage. The current staging system for melanoma is based on the 8th edition of TNM classification issued by the American Joint Committee on Cancer (AJCC) in 2017. It includes a clinical and a pathological staging, both consisting of 5 stages (0-IV). The stage of a melanoma is determined by several factors, among which the Breslow thickness, the pathological presence or absence of ulceration in the primary tumor, the presence and the number of tumor-involved regional lymph nodes, the presence or absence of in-transit, satellite and/or microsatellite metastases, and the presence of distant metastases. Following melanoma diagnosis, an accurate medical workup, in line with the stage and the physical examination, should be performed. A continuous patient monitoring is fundamental to detect a potential relapse or a second primary melanoma and should be lifelong. However, there is still no universally adopted follow-up strategy program and different follow-up schemes have been suggested. Future prospective studies are needed to evaluate different follow-up protocols according to the adopted therapy, as novel recent therapies (targeted and immunotherapies) are being increasingly used. Chryssoula PapageorgiouZoe ApallaSofia-Magdalini ManoliKonstantinos LallasEfstratios VakirlisAimilios LallasMattioli1885articleMelanomastagingfollow-upDermatologyRL1-803ENDermatology Practical & Conceptual, Vol 11, Iss S1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Melanoma staging follow-up Dermatology RL1-803
spellingShingle	Melanoma staging follow-up Dermatology RL1-803 Chryssoula Papageorgiou Zoe Apalla Sofia-Magdalini Manoli Konstantinos Lallas Efstratios Vakirlis Aimilios Lallas Melanoma: Staging and Follow-Up
description	Cancer staging is the process determining to which extent a cancer has spread and where it is located in the body. A thorough staging is of utmost importance, not only because it provides the most accurate prognostic estimation, but also because several crucial decisions, such as the treatment choice and the follow-up strategy, vary according to the tumor’s stage. The current staging system for melanoma is based on the 8th edition of TNM classification issued by the American Joint Committee on Cancer (AJCC) in 2017. It includes a clinical and a pathological staging, both consisting of 5 stages (0-IV). The stage of a melanoma is determined by several factors, among which the Breslow thickness, the pathological presence or absence of ulceration in the primary tumor, the presence and the number of tumor-involved regional lymph nodes, the presence or absence of in-transit, satellite and/or microsatellite metastases, and the presence of distant metastases. Following melanoma diagnosis, an accurate medical workup, in line with the stage and the physical examination, should be performed. A continuous patient monitoring is fundamental to detect a potential relapse or a second primary melanoma and should be lifelong. However, there is still no universally adopted follow-up strategy program and different follow-up schemes have been suggested. Future prospective studies are needed to evaluate different follow-up protocols according to the adopted therapy, as novel recent therapies (targeted and immunotherapies) are being increasingly used.
format	article
author	Chryssoula Papageorgiou Zoe Apalla Sofia-Magdalini Manoli Konstantinos Lallas Efstratios Vakirlis Aimilios Lallas
author_facet	Chryssoula Papageorgiou Zoe Apalla Sofia-Magdalini Manoli Konstantinos Lallas Efstratios Vakirlis Aimilios Lallas
author_sort	Chryssoula Papageorgiou
title	Melanoma: Staging and Follow-Up
title_short	Melanoma: Staging and Follow-Up
title_full	Melanoma: Staging and Follow-Up
title_fullStr	Melanoma: Staging and Follow-Up
title_full_unstemmed	Melanoma: Staging and Follow-Up
title_sort	melanoma: staging and follow-up
publisher	Mattioli1885
publishDate	2021
url	https://doaj.org/article/16a49f013e7d4ebeae8ac1918b14e2c7
work_keys_str_mv	AT chryssoulapapageorgiou melanomastagingandfollowup AT zoeapalla melanomastagingandfollowup AT sofiamagdalinimanoli melanomastagingandfollowup AT konstantinoslallas melanomastagingandfollowup AT efstratiosvakirlis melanomastagingandfollowup AT aimilioslallas melanomastagingandfollowup
_version_	1718425782960783360

Melanoma: Staging and Follow-Up

Ejemplares similares